Conformational Changes Specific for Pseudophosphorylation at Serine 262 Selectively Impair Binding of Tau to Microtubules

2009/09/21 by Daniela Fischer, Marco D. Mukrasch, Jacek Biernat +6 · 25 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Microtubule and mitosis dynamics #Alzheimer's disease research and treatments #Amino Acid Enzymes and Metabolism

paper · doi:10.1021/bi901090m

Abstract

Aggregation of the microtubule-associated protein tau into neurofibrillary tangles is the pathological hallmark of a variety of dementias. For reasons not yet known, tau becomes excessively phosphorylated in Alzheimer's brains and as a result no longer binds properly to microtubules. Here we studied the impact of phosphorylation on the conformational and binding properties of the repeat region of tau (K18) that is necessary for microtubule assembly and forms the core of paired helical filaments. To mimic phosphorylation, we introduced four mutations of serine to glutamate residues at positions 262, 293, 324, and 356. NMR spectroscopy demonstrates that pseudophosphorylation at these sites modifies the structural properties in repeats 1 and 2, in particular for Gln265-Lys267. Gln265-Lys267 are in close proximity to Ser262, the phosphorylation site that most strongly attenuates binding to microtubules. In contrast, the pseudophosphorylation mimic of tau efficiently interacts with the polyanion heparin. Thus, phosphorylation of the repeat region of natively unfolded tau induces specific conformational changes that have a strong impact on its biological function and involvement in disease.

Citations

• Neuropathological stageing of Alzheimer-related changes

Cited by

• Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis. [europepmc]
• The role of tau kinases in Alzheimer's disease. [europepmc]
• The diarylheptanoid (+)-aR,11S-myricanol and two flavones from bayberry (Myrica cerifera) destabilize the microtubule-associated protein tau. [europepmc]
• Constructing ensembles for intrinsically disordered proteins. [europepmc]
• The many faces of tau. [europepmc]
• Expanding the proteome: disordered and alternatively folded proteins. [europepmc]
• Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. [europepmc]
• The microtubule-associated tau protein has intrinsic acetyltransferase activity. [europepmc]
• Tangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing Problem. [europepmc]
• Protein phosphorylation in neurodegeneration: friend or foe? [europepmc]
• Tau phosphorylation at serine 396 residue is required for hippocampal LTD. [europepmc]
• Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity. [europepmc]
• AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo. [europepmc]
• Short and Long Term Behavioral and Pathological Changes in a Novel Rodent Model of Repetitive Mild Traumatic Brain Injury. [europepmc]
• Stabilization of dynamic microtubules by mDia1 drives Tau-dependent Aβ 1-42 synaptotoxicity. [europepmc]
• Structure and Functions of Microtubule Associated Proteins Tau and MAP2c: Similarities and Differences. [europepmc]
• The complexity of tau in Alzheimer's disease. [europepmc]
• Site-Specific Hyperphosphorylation Inhibits, Rather than Promotes, Tau Fibrillization, Seeding Capacity, and Its Microtubule Binding. [europepmc]
• The mechanism of Hsp90-induced oligomerizaton of Tau. [europepmc]
• Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies. [europepmc]
• A novel tau-based rhesus monkey model of Alzheimer's pathogenesis. [europepmc]
• "Don't Phos Over Tau": recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies. [europepmc]
• Possible Mechanisms of Tau Spread and Toxicity in Alzheimer's Disease. [europepmc]
• Alzheimer's disease and its treatment-yesterday, today, and tomorrow. [europepmc]
• Unraveling the complexity of human brain: Structure, function in healthy and disease states. [europepmc]

Related

• Characterization of Phosphorylated Tau-Microtubule complex with Molecular Dynamics (MD) simulation
• Tau Protein and the Neurofibrillary Pathology of Alzheimer's Disease
• The structure of a Tau fragment bound to tubulin prompts new hypotheses on Tau mechanism and oligomerization
• Tau hyperphosphorylation impairs cooperative binding to microtubules and perturbs organelle trafficking in neurons
• Targeting Post-translational Modifications on Tau as a Therapeutic Strategy for Alzheimer's Disease